688363 華熙生物
按盤價 
44.180 +0.560 (+1.284%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.639 | 2.534 | 8.728 | 15.745 | 14.597 |
| 總資產報酬率 ROA (%) | 2.947 | 2.035 | 6.910 | 11.997 | 11.835 |
| 投入資產回報率 ROIC (%) | 3.456 | 2.411 | 8.259 | 14.678 | 13.979 | 邊際利潤分析 |
| 銷售毛利率 (%) | 70.685 | 74.071 | 73.320 | 76.990 | 78.066 |
| 營業利潤率 (%) | 9.221 | 4.021 | 11.659 | 17.869 | 18.302 |
| 息稅前利潤/營業總收入 (%) | 8.815 | 3.844 | 11.042 | 17.101 | 17.982 |
| 淨利潤/營業總收入 (%) | 7.976 | 3.136 | 9.591 | 15.118 | 15.675 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 107.334 | 155.071 | 90.875 | 91.276 | 87.827 |
| 價值變動淨收益/利潤總額(%) | -2.796 | -5.212 | 0.398 | 1.036 | 3.150 |
| 營業外收支淨額/利潤總額(%) | -0.057 | -1.193 | -0.950 | -0.018 | -1.725 | 償債能力分析 |
| 流動比率 (X) | 2.499 | 2.044 | 2.558 | 2.447 | 2.845 |
| 速動比率 (X) | 1.419 | 1.113 | 1.629 | 1.741 | 2.338 |
| 資產負債率 (%) | 16.286 | 20.989 | 17.551 | 23.023 | 24.005 |
| 帶息債務/全部投入資本 (%) | 0.384 | 0.234 | 0.173 | 3.478 | 2.381 |
| 股東權益/帶息債務 (%) | 24,956.413 | 40,161.142 | 55,551.426 | 2,675.714 | 3,924.090 |
| 股東權益/負債合計 (%) | 511.836 | 374.818 | 467.119 | 331.894 | 316.387 |
| 利息保障倍數 (X) | -21.999 | -29.680 | -21.787 | -22.350 | -1,798.523 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 46.647 | 33.188 | 26.538 | 23.920 | 27.976 |
| 存貨周轉天數 (天) | 345.188 | 307.927 | 254.954 | 230.122 | 196.693 |
| 備註： | 即時報價更新時間為 19/12/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
